OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
07/09/2026
Back to search
Official data from USPTO
NOVARTIS RLT CARE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000079415080Class
35, 39, 41, 44
Filing
79415080
Registration
7943200
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
07/09/2026
Trademark type
Combined
Nice classes
35, 39, 41, 44
Filing date
11/06/2024
Registration date
09/16/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/16/2025
Last transaction
07/09/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
03
Owner location
CH
Examiner
MAHMOUDI, MARIAM AZIZ
Law office
M60
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Novartis AG
Representatives
Maury M. Tepper, III Tepper & Eyster, PLLC
Technical classification
Nice Classes
Class 35Class 39Class 41Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consulting services in the field of implementationpractice and operation of radioligand imaging and radioligand therapy centers; online ordering services featuring ligands and radioligands; business administrative services for medical referrals
Class 39
Delivery of vials containing ligands and radioligands.
Class 41
Educational servicesproviding on-line classesseminars and workshops for healthcare professionals in the field of radioligand imaging and radioligand therapy.
Class 44
Providing health information; Providing medical information in the field of radioligand imaging and radioligand therapy.
Publications
History of USPTO decisions and trademark events.
30 publications found
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/22/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
06/22/2026
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/16/2026
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/30/2026
FIMP
FINAL DISPOSITION PROCESSED
03/30/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/16/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/16/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
09/16/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/29/2025
PUBO
PUBLISHED FOR OPPOSITION
07/29/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/23/2025
RFNT
REFUSAL PROCESSED BY IB
07/05/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/23/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/20/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/20/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/20/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/13/2025
RFRR
REFUSAL PROCESSED BY MPU
06/13/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
04/07/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/07/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/07/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/07/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/07/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/29/2025
CNRT
NON-FINAL ACTION WRITTEN
03/28/2025
DOCK
ASSIGNED TO EXAMINER
03/27/2025
MAFR
APPLICATION FILING RECEIPT MAILED
01/29/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/29/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/23/2025
Continuous trademark protection
Get notified about every new filing that threatens NOVARTIS RLT CARE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.